Search research articles
Contact Us
Filters
Showing results (211-220 of 282) with videos related to
Page
of 29
Sort By:
Annals of Neurology
|
February 1, 1984
Central nervous system catecholamine metabolism in Korsakoff's psychosis
P R Martin, H Weingartner, E K Gordon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 9, 2003
Association of a critical CSF tryptophan threshold level with depressive relapse
Ronald M Salomon, John S Kennedy, Benjamin W Johnson, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
August 11, 2011
Inhomogeneous alloying in FePt nanoparticles as a reason for reduced magnetic moments
C Antoniak, M Spasova, A Trunova, et al.
Neuroendocrinology
|
December 1, 1994
Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies
T D Geracioti, P T Loosen, M H Ebert, et al.
Journal of Abnormal Psychology
|
February 1, 1980
Cognitive processes in normal and hyperactive children and their response to amphetamine treatment
H Weingartner, J L Rapoport, M S Buchsbaum, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1984
Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPG
I J Kopin, P Blombery, M H Ebert, et al.
Neurology
|
August 1, 1984
Alpha-adrenergic receptors in orthostatic hypotension syndromes
M S Kafka, R J Polinsky, A Williams, et al.
Chemical & Pharmaceutical Bulletin
|
January 20, 1998
Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity
W A Hewlett, T de Paulis, N S Mason, et al.
Journal of Virology
|
March 10, 2001
Adaptation of reovirus to growth in the presence of protease inhibitor E64 segregates with a mutation in the carboxy terminus of viral outer-capsid protein sigma3
D H Ebert, J D Wetzel, D E Brumbaugh, et al.
Pharmacology, Biochemistry, and Behavior
|
August 18, 2001
Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze
Z J Zhang, D E Schmidt, T de Paulis, et al.
Page
of 29
Search research articles
Search
Showing results (211-220 of 282) with videos related to
Sort By:
Page
of 29
Annals of Neurology
|
February 1, 1984
Central nervous system catecholamine metabolism in Korsakoff's psychosis
P R Martin, H Weingartner, E K Gordon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 9, 2003
Association of a critical CSF tryptophan threshold level with depressive relapse
Ronald M Salomon, John S Kennedy, Benjamin W Johnson, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
August 11, 2011
Inhomogeneous alloying in FePt nanoparticles as a reason for reduced magnetic moments
C Antoniak, M Spasova, A Trunova, et al.
Neuroendocrinology
|
December 1, 1994
Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies
T D Geracioti, P T Loosen, M H Ebert, et al.
Journal of Abnormal Psychology
|
February 1, 1980
Cognitive processes in normal and hyperactive children and their response to amphetamine treatment
H Weingartner, J L Rapoport, M S Buchsbaum, et al.
Advances in Biochemical Psychopharmacology
|
January 1, 1984
Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPG
I J Kopin, P Blombery, M H Ebert, et al.
Neurology
|
August 1, 1984
Alpha-adrenergic receptors in orthostatic hypotension syndromes
M S Kafka, R J Polinsky, A Williams, et al.
Chemical & Pharmaceutical Bulletin
|
January 20, 1998
Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity
W A Hewlett, T de Paulis, N S Mason, et al.
Journal of Virology
|
March 10, 2001
Adaptation of reovirus to growth in the presence of protease inhibitor E64 segregates with a mutation in the carboxy terminus of viral outer-capsid protein sigma3
D H Ebert, J D Wetzel, D E Brumbaugh, et al.
Pharmacology, Biochemistry, and Behavior
|
August 18, 2001
Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT(3) receptor antagonist, in the mouse elevated plus-maze
Z J Zhang, D E Schmidt, T de Paulis, et al.
Page
of 29